Status:

UNKNOWN

Utilisation of Telemedicine in Optimal Cardiac Rehabilitation Program in Patients After Myocardial Revascularization

Lead Sponsor:

Pawel Buszman

Conditions:

Coronary Artery Disease With Myocardial Infarction

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Although clinical data demonstrate advantages of combining complete revascularization with optimal cardiac rehabilitation (CR) less than one-third of patients in European countries participate in card...

Detailed Description

Although clinical data demonstrate advantages of combining complete revascularization with optimal cardiac rehabilitation (OCR) less than one-third of patients in European countries participate in car...

Eligibility Criteria

Inclusion

  • age over 18 and below 70
  • completed revascularization in patients with stable or unstable angina or after myocardial infarction without ST-segment elevation (NSTEMI)
  • in patients with suspected myocardial scars, MRI will be recommended to confirm myocardial viability.
  • eligibility to participate in a program of early cardiac rehabilitation
  • signed informed consent form
  • the ability to use telerehabilitation system

Exclusion

  • acute myocardial infarction with ST segment elevation/new onset of left bundle branch block (LBBB),
  • suboptimal (not completed) revascularisation
  • ejection fraction \<40%.
  • acute heart failure (Killip IV) at the time of admission to the hospital
  • dual antiplatelet therapy can not be maintained for 1 year after PCI
  • haemorrhagic stroke in the past
  • ischemic stroke or transient ischemia in previous 6 weeks
  • platelet count \<100,000 / mm3
  • chronic renal failure with creatinine clearance \<30ml / min / 1.73m2
  • planned surgery
  • pregnancy or planned pregnancies
  • expected life expectancy less than 3 years after enrollment

Key Trial Info

Start Date :

March 28 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2020

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT03375944

Start Date

March 28 2018

End Date

July 1 2020

Last Update

May 30 2018

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Malopolskie Centrum Sercowo-Naczyniowe

Chrzanów, Lesser Poland Voivodeship, Poland, 32-500

2

IV Oddział Kardiologii Inwazyjnej, Elektrostymulacji i Angiologii

Kedzierzyn Kozle, Lower Silesian Voivodeship, Poland, 47-200

3

II Oddział Kardiologiczny

Bielsko-Biala, Upper Silesia, Poland, 43-316

4

III Oddział Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii

Dąbrowa Górnicza, Upper Silesia, Poland, 41-300